6.3 Enteral & Parenteral Nutrition Support in Older Adults

6.3 Enteral & Parenteral Nutrition Support in Older Adults

Specialized nutrition support in older adults requires rigorous clinical judgment that balances physiological benefit against procedural risk, metabolic complications, and person-centered goals of care. In geriatric practice, the decision to initiate enteral nutrition (EN) or parenteral nutrition (PN) demands careful consideration of gastrointestinal functionality, underlying disease reversibility, life expectancy, and ethical directives.

---

1. Clinical Indications and Contraindications for Enteral Nutrition

The foundational physiological axiom of nutrition support is: if the gut works, use it. Intraluminal nutrients preserve intestinal mucosal architecture, sustain tight junction integrity, stimulate gut-associated lymphoid tissue (GALT), and prevent bacterial translocation.

Diagnostic Indications

• Oral Inadequacy: Consider EN when oral intake cannot meet needs despite appropriate support and there is a functional GI tract with a reasonable expected benefit. Assess urgency from malnutrition and projected duration rather than waiting a fixed number of days for every patient.
• Severe Neurological Dysphagia: Acute stroke with persistent severe oropharyngeal dysphagia, traumatic brain injury, or advanced bulbar amyotrophic lateral sclerosis (ALS) where oral intake presents an unmanageable aspiration risk.
• Hypercatabolic Illness and Critical Care: Prolonged mechanical ventilation, severe head and neck oncology, or critical medical illness.

Absolute and Relative Contraindications

• GI Conditions Requiring Review: Complete obstruction or bowel ischemia may make EN unsafe. Vomiting, diarrhea, ileus, or a fistula require assessment of cause, severity, and available access; diarrhea alone is not an absolute EN contraindication.
• Hemodynamic Instability / Shock: Severe shock with mean arterial pressure (MAP) $<65\text{ mmHg}$ or escalating vasopressor requirements. Enteral feeding during severe mesenteric hypoperfusion carries high risk for non-occlusive mesenteric ischemia (NOMI) and bowel necrosis.
• Ethical and Clinical Consensus in Advanced Dementia: Clinical consensus statements from the American Geriatrics Society (AGS), ASPEN, AMDA, and the American Academy of Hospice and Palliative Medicine (AAHPM) strongly recommend against tube feeding in patients with advanced dementia. Available evidence, largely observational, has not established that routine tube feeding in advanced dementia improves survival, aspiration outcomes, pressure-injury healing, or function compared with careful hand feeding, while increasing physical agitation, restraint use, and emergency transfers.

---

2. Enteral Access Modalities: Short-Term vs. Long-Term

Selection of enteral access depends on the projected duration of therapy, aspiration risk, and gastric motility:

---

3. Enteral Formula Selection in Older Adults

Formulas must be tailored to the resident's fluid tolerance, organ function, and digestive capacity:

• Standard Polymeric Formulas ($1.0\text{ to } 1.2\text{ kcal/mL}$): Contain intact cow milk protein (casein, whey) or soy protein isolates, complex carbohydrates (maltodextrin), and long-chain triglycerides. Isotonic ($300\text{ to } 400\text{ mOsm/kg}$), providing approximately $80\text{ to } 85\%$ free water. First-line for older adults with intact digestion and normal fluid tolerance.
• Concentrated Polymeric Formulas ($1.5\text{ to } 2.0\text{ kcal/mL}$): Provide high caloric and protein density in limited volume ($65\text{ to } 75\%$ free water). Indicated for volume-restricted elders with congestive heart failure, severe oliguric renal failure, or chronic hyponatremia. Require careful monitoring for dehydration and hyperosmolality.
• Fiber-Enriched Formulas: Contain soluble fiber (fructooligosaccharides, guar gum) and insoluble fiber (soy polysaccharide). Fiber stimulates colonic microbial production of short-chain fatty acids (SCFAs), nourishing colonocytes and normalizing bowel transit (reducing both diarrhea and constipation). Avoid insoluble fiber in severe dysmotility or acute bowel ischemia.
• Semi-Elemental / Peptide-Based Formulas: Contain enzymatically hydrolyzed whey or soy peptides, free amino acids, and high proportions of medium-chain triglycerides (MCTs). MCTs are more readily digested/absorbed and less dependent on bile-mediated micelles than long-chain fats, but do not eliminate every need for digestive function. Indicated for malabsorption syndromes, chronic pancreatitis, severe short bowel syndrome, or gut mucosal atrophy following prolonged fasting.

---

4. Refeeding Syndrome in Older Adults: Pathophysiology and Prevention

Refeeding syndrome is a potentially fatal metabolic complication occurring when malnourished, catabolic, or starved patients are rapidly reintroduced to carbohydrate-rich nutrition:

Pathophysiological Cascade

1. Prolonged Starvation State: Prolonged inadequate intake exhausts hepatic glycogen stores. The body shifts to fat catabolism (ketogenesis) and protein proteolysis. Total body intracellular pools of phosphorus, potassium, and magnesium become severely depleted, even though serum concentrations may appear falsely normal due to hemoconcentration and intracellular-to-extracellular shifts.
2. Carbohydrate Reintroduction & Insulin Surge: Infusing enteral or parenteral carbohydrates triggers a rapid surge in insulin secretion from pancreatic beta cells.
3. Intracellular Electrolyte Influx: Insulin activates sodium-potassium ATPase pumps, driving potassium into cells. Simultaneously, insulin drives glucose, magnesium, and phosphate intracellularly for phosphorylation of adenosine diphosphate (ADP) to adenosine triphosphate (ATP) and cellular glycolysis.
4. The Hallmark Biochemical Triad:
   • Hypophosphatemia (severe typically below $1.0\text{ mg/dL}$): Cellular ATP depletion causes respiratory failure (diaphragmatic weakness), acute congestive heart failure (impaired myocardial contractility), rhabdomyolysis, seizures, and death.
   • Hypokalemia ($<3.5\text{ mEq/L}$): Induces severe cardiac arrhythmias (ventricular tachycardia, fibrillation, cardiac arrest), neuromuscular paralysis, and paralytic ileus.
   • Hypomagnesemia ($<1.8\text{ mg/dL}$): Causes cardiac arrhythmias (torsades de pointes, QT prolongation), tremors, tetany, and refractory hypokalemia/hypocalcemia.
5. Acute Thiamine (Vitamin B1) Consumption: Thiamine is an indispensable coenzyme for pyruvate dehydrogenase in the citric acid cycle. Carbohydrate reintroduction rapidly exhausts remaining thiamine stores, precipitating Wernicke's encephalopathy (confusion, ataxia, ophthalmoplegia) and acute lactic acidosis.

Recognizing and Preventing Refeeding Syndrome

ASPEN’s 2020 consensus defines refeeding syndrome by a fall in phosphorus, potassium, or magnesium within five days of calorie reintroduction: 10–20% for mild, 20–30% for moderate, or more than 30% and/or related organ dysfunction or thiamine deficiency for severe. All three electrolytes need not fall, and an absolute phosphorus value alone does not establish the diagnosis.

Check baseline potassium, magnesium, and phosphorus and correct deficiencies. Severe deficits can justify delaying calorie initiation or advancement. Include calories from oral food, EN, PN, and IV dextrose. In high-risk adults, ASPEN recommends checking these electrolytes every 12 hours for the first three days, with frequency adjusted to the clinical picture.

ASPEN recommends 100 mg thiamine before planned feeding or dextrose-containing IV fluids and daily for five to seven days or longer with severe starvation, chronic alcohol use, or other high risk. Suspected Wernicke encephalopathy needs urgent medical treatment beyond a routine preventive regimen. Emergency glucose for hypoglycemia must not be delayed while awaiting thiamine.

An ASPEN starting range is 10–20 kcal/kg in the first 24 hours, advancing by about one-third of goal every one to two days according to response. Other protocols may differ; extremely high risk or instability requires specialist individualization. Monitor fluid balance, vital signs, glucose, weight, and symptoms as well as electrolytes. Fixed daily rate increases despite falling electrolytes are unsafe.

---

5. Parenteral Nutrition in Geriatrics: Indications and Complications

Parenteral nutrition (PN) bypasses the gastrointestinal tract, delivering crystalline amino acids, dextrose, lipid emulsions, electrolytes, vitamins, and trace elements directly into the venous circulation:

Peripheral (PPN) vs. Central (CPN / TPN)

• PPN: Uses peripheral access and a lower-osmolarity solution; about 900 mOsm/L is a commonly used maximum reference, with local limits and tolerance considered. Large required volumes often limit adequacy in fluid-sensitive patients. Duration, formulation, and access are individualized.
• Central Parenteral Nutrition (CPN / TPN): Infused via central venous access (PICC or tunneled catheter) into the superior vena cava. Permits hypertonic solutions ($>900\text{ mOsm/L}$, dextrose $20\text{ to } 30\%$). Provides full macro- and micronutrient repletion for extended durations.

PN is considered when oral/enteral intake is impossible or persistently insufficient and expected benefit justifies risks. It may supplement inadequate EN. Timing depends on nutritional status, condition, and prognosis; it is not restricted to one list of prolonged GI diagnoses.

Geriatric Risks and Complications

• Catheter-Related Bloodstream Infections (CRBSI): Immunosenescent older adults face elevated risk of life-threatening fungal (Candida) and bacterial (Staphylococcus aureus) central line sepsis.
• Metabolic Derangements: Severe hyperglycemia from age-related insulin resistance (individualize glucose goals; ADA generally uses 140–180 mg/dL for most critically ill patients and 100–180 mg/dL for most noncritically ill inpatients when achievable without significant hypoglycemia), hyperosmolar hyperglycemic state (HHS), and severe electrolyte shifts.
• Hepatic Steatosis and Cholestasis: Reduced enteral stimulation may contribute to gallbladder stasis; overfeeding, infection, illness, and other factors can contribute to liver abnormalities. Review the prescription and clinical causes rather than assigning one mechanism to every case.
• Fluid Overload: Excess administered fluid and sodium, impaired excretion, and refeeding-related retention can worsen heart failure. Count all fluids and monitor balance; hypertonicity alone does not make every PN infusion cause overload.

---

6. Clinical Case Scenario

A 79-year-old male with chronic alcoholism and severe depression is admitted with severe malnutrition (BMI $16.2\text{ kg/m}^2$, weight 48 kg). He has consumed only tea and crackers for 3 weeks. An NG tube is placed. Baseline labs reveal serum phosphorus $2.2\text{ mg/dL}$, potassium $3.3\text{ mEq/L}$, and magnesium $1.5\text{ mg/dL}$.

• Illustrative Plan: The team holds planned full-rate feeding, gives thiamine, and treats electrolyte deficits. If clinically appropriate, a 1-kcal/mL formula at 20 mL/hour for 24 hours supplies 480 kcal, or 10 kcal/kg for this 48-kg patient. Monitor potassium, magnesium, and phosphorus at least every 12 hours initially under the high-risk protocol. Advance only after reassessment of electrolytes, fluid balance, glucose, and symptoms; do not increase automatically each day.

---

7. Decisions to Practice

• Refeeding involves changes after calorie delivery; baseline deficiency alone is not the syndrome.
• Use the selected protocol for thiamine, cautious calories, electrolyte replacement, and close monitoring.
• Stabilize uncontrolled shock before EN; one isolated blood-pressure value is not a complete assessment.
• Jejunal access does not automatically require an elemental formula.
• Discuss goals, benefits, burdens, and alternatives before artificial nutrition, especially with advanced dementia.

Primary source check

ASPEN refeeding consensus, checked October 13, 2026.

ADA inpatient glucose guidance 2026, checked October 13, 2026.